Skip to main content

Table 2 Culture and Infectious consultation

From: Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital

Criteria

Work done

Work not done

Microbiology and culture test within 24 h

250 (83.3%)

50 (16.7%)

Infectious disease consultation

178 (59.3%)

122 (40.7%)

Starting as an empiric therapy in accordance with ADSA guidelines

286 (95.3%)

14 (4.7%)

Dosing, dose adjustments accordance to a drug data base reference (Lexi comp).

14(5%)

8 (2.7%)